Join Our

Online Banking

Top Ten

Online Stock Trading

Bulletin Board

Stock Market Quotes

Gifts, Shopping

Pink Sheets

Page Builder

CME Globex2 Session

Live Chat Online Trading

Charts & Charting

Currency Rates

Free Auto-refreshin g Custom Pages!


Stock Picks

Real-time News Pages

Internet Lingo

Investment Books

Links Worlds Largest

Stock Quotes


Market Makers A-Z

Message Boards

News and Charts

Online Brokers W/ Phone Numbers

Options Information

Complete listing OTCBB Issues

Overseas Markets

Penny Stocks

S&P Fair Value

SI People & Subject

Site Map

Slang, Internet

Stock Markets

World Markets


Active Stocks


Privacy Policy

Affiliate Programs


NASCAR Schedule

PGA Schedule





Medical Marijuana, Inc. Announces Historic Registration of its CBD Products in Paraguay as a Medicine


Official Product Registration Makes Medical Marijuana, Inc. Cannabis Products First Available Through Medical Distribution Channels in Paraguay

SAN DIEGO, Jan. 9, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced the historic registration of its Real Scientific Hemp Oil-X™ (RSHO-X™) and RSHO™-Blue Label products as registered medicines by Paraguay's national health regulation organization (Dirección Nacional de Vigilancia Sanitaria).

"We are a Company of firsts and we are excited about this new historic milestone of being the first company to have a CBD product registered in Paraguay," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

"We have actively pursued getting our pipeline of botanical cannabis products registered and approved as therapeutic products in countries around the world, which opens the ability for international pharmacies and healthcare providers to distribute cannabis products to patients," added Dr. Titus. "This is yet another example of the international trend of acceptance of CBD for therapeutic use, and we are continually encouraged by the decisions of governments and regulators to permit use of cannabis and CBD products for patients suffering from multiple indications - especially where conventional medicine has had modest or limited effects."

Paraguay's official registration of Medical Marijuana, Inc.'s CBD hemp oil products marks the first country that has registered and approved the Company's products as medicinal products. Currently, Medical Marijuana, Inc.'s CBD hemp oil products have been used in Paraguay with medical indications ranging from cancer, pain, multiple sclerosis, epilepsy and various other neurological diseases. 

Prior to becoming registered as official medicines, in May of 2016, Real Scientific Hemp Oil™ became the first medical cannabis product approved and imported for use in Paraguay for compassionate use with a prescription and government permission. This event marked the third time in a little over a year that RSHO™ was the first cannabis product approved in a Latin American country, following the lead of Brazil and Mexico.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Public Relations Contact:
Andrew Hard
Chief Executive Officer CMW Media
P. 888-829- 0070


Cision View original content:

SOURCE Medical Marijuana, Inc.

Back to top

RELATED LINKS  Links  Search   Disclaimer  About Us Advertising

© 1995, 1996, 1997, 1998,1999, 2000, 2001 All rights reserved.